nach oben

Current Anesthesiology Reports

Erschienen in:

13.09.2022 | Patient Safety in Anesthesia (SJ Brull and JR Renew, Section Editors)

Management of Neuromuscular Block in Pediatric Patients — Safety Implications

verfasst von: Young May Cha, Debra J. Faulk

Erschienen in: Current Anesthesiology Reports | Ausgabe 4/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

We summarize the current status of neuromuscular blockade monitoring and reversal strategies in children, and the gaps that exist in our knowledge and approach compared to adult practice.

Recent Findings

Children experience residual neuromuscular blockade and are at risk of subsequent complications, though this is less well studied compared to adults. Objective (quantitative) monitoring of neuromuscular blockade in children has been challenging due to patient size and surgical positioning. Recent dosing indications for sugammadex in children and advances in objective monitoring may provide measures to improve patient safety in daily pediatric anesthesia practice.

Summary

As evidence-based practice guidelines are formed, investigations supporting the safe use, monitoring, and reversal of neuromuscular blockade in children are needed. Objective monitoring for appropriate management and reversal of neuromuscular blockade in children should be encouraged, even when using sugammadex.

Search Strategy

A PubMed search was completed using key terms “pediatric anesthesia,” “residual neuromuscular blockade,” “neuromuscular monitoring,” “quantitative monitoring,” and “sugammadex.” The search was conducted in July 2022 and was restricted to English literature. The search included meta-analyses, randomized controlled trials, clinical trials, observational studies, case reports, and reviews within the past 20 years.

Murphy GS, Brull SJ. Quantitative neuromuscular monitoring and postoperative outcomes: A narrative review. Anesthesiology. 2022;136(2):345–61. https://doi.org/10.1097/ALN.0000000000004044.CrossRef

Saager L, Maiese EM, Bash LD, Meyer TA, Minkowitz H, Groudine S, et al. Incidence, risk factors, and consequences of residual neuromuscular block in the United States: the prospective, observational, multicenter RECITE-US study. J Clin Anesth. 2019;55:33–41. https://doi.org/10.1016/j.jclinane.2018.12.042.CrossRef

Naguib M, Kopman AF, Lien CA, Hunter JM, Lopez A, Brull SJ. A survey of current management of neuromuscular block in the United States and Europe. Anesth Analg. 2010;111(1):110–9. https://doi.org/10.1213/ANE.0b013e3181c07428.CrossRef

Kotake Y, Ochiai R, Suzuki T, Ogawa S, Takagi S, Ozaki M, et al. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block. Anesth Analg. 2013;117(2):345–51. https://doi.org/10.1213/ANE.0b013e3182999672.CrossRef

Naguib M, Brull SJ, Kopman AF, Hunter JM, Fulesdi B, Arkes HR, et al. Consensus statement on perioperative use of neuromuscular monitoring. Anesth Analg. 2018;127(1):71–80. https://doi.org/10.1213/ANE.0000000000002670.CrossRef

Nemes R, Renew JR. Clinical practice guideline for the management of neuromuscular blockade: what are the recommendations in the USA and other countries? Curr Anesthesiol Rep. 2020;10(2):90–8. https://doi.org/10.1007/s40140-020-00389-3.CrossRef

Blobner M, Hollmann MW, Luedi MM, Johnson KB. Pro-con debate: do we need quantitative neuromuscular monitoring in the era of sugammadex? Anesth Analg. 2022;135(1):39–48. https://doi.org/10.1213/ANE.0000000000005925.CrossRef

•• Faulk DJ, Austin TM, Thomas JJ, Strupp K, Macrae AW, Yaster M. A survey of the society for pediatric anesthesia on the use, monitoring, and antagonism of neuromuscular blockade. Anesth Analg. 2021;132(6):1518–26. https://doi.org/10.1213/ANE.0000000000005386Survey of pediatric anesthesia providers in the U.S. showing decreased use of train-of-four monitoring in recent graduates who tend to use sugammadex.CrossRef

•• Klucka J, Kosinova M, Krikava I, Stoudek R, Toukalkova M, Stourac P. Residual neuromuscular block in paediatric anaesthesia. Br J Anaesth. 2019;122(1):e1–2. https://doi.org/10.1016/j.bja.2018.10.001Prospective observational cohort study showing high rates of residual neuromuscular blockade in PACU as measured by acceleromyography.CrossRef

10.

Vested M, Tarpgaard M, Eriksen K, Rasmussen LS. Incidence of residual neuromuscular blockade in children below 3 years after a single bolus of cisatracurium 0.1 mg/kg: a quality assurance study. Acta Anaesthesiol Scand. 2020;64(2):168–72. https://doi.org/10.1111/aas.13495.CrossRef

11.

•• Ledowski T, O’Dea B, Meyerkort L, Hegarty M, von Ungern-Sternberg BS. Postoperative residual neuromuscular paralysis at an Australian tertiary children’s hospital. Anesthesiol Res Pract. 2015;2015: 410248. https://doi.org/10.1155/2015/410248Audit of Australian tertiary pediatric center showing high rates of residual neuromuscular blockade even after a reversal agent was given.CrossRef

12.

Fortier LP, McKeen D, Turner K, de Medicis E, Warriner B, Jones PM, et al. The RECITE study: a Canadian prospective, multicenter study of the incidence and severity of residual neuromuscular blockade. Anesth Analg. 2015;121(2):366–72. https://doi.org/10.1213/ANE.0000000000000757.CrossRef

13.

Nemes R, Fulesdi B, Pongracz A, Asztalos L, Szabo-Maak Z, Lengyel S, et al. Impact of reversal strategies on the incidence of postoperative residual paralysis after rocuronium relaxation without neuromuscular monitoring: a partially randomised placebo controlled trial. Eur J Anaesthesiol. 2017;34(9):609–16. https://doi.org/10.1097/EJA.0000000000000585.CrossRef

14.

Murphy GS, Szokol JW, Marymont JH, Greenberg SB, Avram MJ, Vender JS, et al. Intraoperative acceleromyographic monitoring reduces the risk of residual neuromuscular blockade and adverse respiratory events in the postanesthesia care unit. Anesthesiology. 2008;109(3):389–98. https://doi.org/10.1097/ALN.0b013e318182af3b.CrossRef

15.

Murphy GS, Szokol JW, Avram MJ, Greenberg SB, Marymont JH, Vender JS, et al. Intraoperative acceleromyography monitoring reduces symptoms of muscle weakness and improves quality of recovery in the early postoperative period. Anesthesiology. 2011;115(5):946–54. https://doi.org/10.1097/ALN.0b013e3182342840.CrossRef

16.

Meretoja OA. Neuromuscular blocking agents in paediatric patients: influence of age on the response. Anaesth Intensive Care. 1990;18(4):440–8. https://doi.org/10.1177/0310057x9001800403.CrossRef

17.

Driessen JJ, Robertson EN, Van Egmond J, Booij LH. The time-course of action and recovery of rocuronium 0.3 mg x kg(-1) in infants and children during halothane anaesthesia measured with acceleromyography. Paediatr Anaesth. 2000;10(5):493–7. https://doi.org/10.1046/j.1460-9592.2000.00543.x.CrossRef

18.

Rapp HJ, Altenmueller CA, Waschke C. Neuromuscular recovery following rocuronium bromide single dose in infants. Paediatr Anaesth. 2004;14(4):329–35. https://doi.org/10.1046/j.1460-9592.2003.01216.x.CrossRef

19.

Taivainen T, Meretoja OA, Erkola O, Rautoma P, Juvakoski M. Rocuronium in infants, children and adults during balanced anaesthesia. Paediatr Anaesth. 1996;6(4):271–5. https://doi.org/10.1111/j.1460-9592.1996.tb00449.x.CrossRef

20.

Meakin GH. Neuromuscular blocking drugs in infants and children. Continuing Educ Anaesth Critical Care Pain. 2007;7(5):143–7. https://doi.org/10.1093/bjaceaccp/mkm032.CrossRef

21.

Meretoja OA. Neuromuscular block and current treatment strategies for its reversal in children. Paediatr Anaesth. 2010;20(7):591–604. https://doi.org/10.1111/j.1460-9592.2010.03335.x.CrossRef

22.

Gilbertson LE, Fiedorek MC, Fiedorek CS, Trinh TA, Lam H, Austin TM. Prolonged neuromuscular block after rocuronium administration in laparoscopic pyloromyotomy patients: a retrospective bayesian regression analysis. Paediatr Anaesth. 2021;31(3):290–7. https://doi.org/10.1111/pan.14118.CrossRef

23.

Soffer OD, Kim A, Underwood E, Hansen A, Cornelissen L, Berde C. Neurophysiological assessment of prolonged recovery from neuromuscular blockade in the neonatal intensive care unit. Front Pediatr. 2020;8:580. https://doi.org/10.3389/fped.2020.00580.CrossRef

24.

Meretoja OA, Taivainen T, Jalkanen L, Wirtavuori K. Synergism between atracurium and vecuronium in infants and children during nitrous oxide-oxygen-alfentanil anaesthesia. Br J Anaesth. 1994;73(5):605–7. https://doi.org/10.1093/bja/73.5.605.CrossRef

25.

von Ungern-Sternberg BS, Hammer J, Schibler A, Frei FJ, Erb TO. Decrease of functional residual capacity and ventilation homogeneity after neuromuscular blockade in anesthetized young infants and preschool children. Anesthesiology. 2006;105(4):670–5. https://doi.org/10.1097/00000542-200610000-00010.CrossRef

26.

Trachsel D, Svendsen J, Erb TO, von Ungern-Sternberg BS. Effects of anaesthesia on paediatric lung function. Br J Anaesth. 2016;117(2):151–63. https://doi.org/10.1093/bja/aew173.CrossRef

27.

Isono S, Tanaka A, Ishikawa T, Nishino T. Developmental changes in collapsibility of the passive pharynx during infancy. Am J Respir Crit Care Med. 2000;162(3 Pt 1):832–6. https://doi.org/10.1164/ajrccm.162.3.9911089.CrossRef

28.

Adewale L. Anatomy and assessment of the pediatric airway. Paediatr Anaesth. 2009;19(Suppl 1):1–8. https://doi.org/10.1111/j.1460-9592.2009.03012.x.CrossRef

29.

Videira RL, Vieira JE. What rules of thumb do clinicians use to decide whether to antagonize nondepolarizing neuromuscular blocking drugs? Anesth Analg. 2011;113(5):1192–6. https://doi.org/10.1213/ANE.0b013e31822c986e.CrossRef

30.

Viby-Mogensen J, Jensen NH, Engbaek J, Ording H, Skovgaard LT, Chraemmer-Jorgensen B. Tactile and visual evaluation of the response to train-of-four nerve stimulation. Anesthesiology. 1985;63(4):440–3. https://doi.org/10.1097/00000542-198510000-00015.CrossRef

31.

Thilen SR, Hansen BE, Ramaiah R, Kent CD, Treggiari MM, Bhananker SM. Intraoperative neuromuscular monitoring site and residual paralysis. Anesthesiology. 2012;117(5):964–72. https://doi.org/10.1097/ALN.0b013e31826f8fdd.CrossRef

32.

Larsen PB, Gatke MR, Fredensborg BB, Berg H, Engbaek J, Viby-Mogensen J. Acceleromyography of the orbicularis oculi muscle II: comparing the orbicularis oculi and adductor pollicis muscles. Acta Anaesthesiol Scand. 2002;46(9):1131–6. https://doi.org/10.1034/j.1399-6576.2002.460912.x.CrossRef

33.

Khandkar C, Liang S, Phillips S, Lee CY, Stewart PA. Comparison of kinemyography and electromyography during spontaneous recovery from non-depolarising neuromuscular blockade. Anaesth Intensive Care. 2016;44(6):745–51. https://doi.org/10.1177/0310057X1604400618.CrossRef

34.

Stewart PA, Freelander N, Liang S, Heller G, Phillips S. Comparison of electromyography and kinemyography during recovery from non-depolarising neuromuscular blockade. Anaesth Intensive Care. 2014;42(3):378–84. https://doi.org/10.1177/0310057X1404200316.CrossRef

35.

Salminen J, van Gils M, Paloheimo M, Yli-Hankala A. Comparison of train-of-four ratios measured with Datex-Ohmeda’s M-NMT MechanoSensor and M-NMT ElectroSensor. J Clin Monit Comput. 2016;30(3):295–300. https://doi.org/10.1007/s10877-015-9717-4.CrossRef

36.

Gaffar EA, Fattah SA, Atef HM, Omera MA, Abdel-Aziz MA. Kinemyography (KMG) versus electromyography (EMG) neuromuscular monitoring in pediatric patients receiving cisatracurium during general anesthesia. Egyptian Journal of Anaesthesia. 2013;29(3):247–53. https://doi.org/10.1016/j.egja.2013.02.006.CrossRef

37.

Abdel-Ghaffar M, Ismail S, Omera M, Atef H, Abdel-Aziz M. Kinemyography (KMG) versus electromyography (EMG) neuromuscular monitoring in pediatric patients receiving Rocuronium during general anesthesia: 3AP1–4. Eur J Anaesthesiol. 2013;30:38 (00003643-201306001-00117).CrossRef

38.

Murphy GS, Szokol JW, Avram MJ, Greenberg SB, Shear TD, Deshur M, et al. Comparison of the TOFscan and the TOF-Watch SX during recovery of neuromuscular function. Anesthesiology. 2018;129(5):880–8. https://doi.org/10.1097/ALN.0000000000002400.CrossRef

39.

Yhim HB, Jang YE, Lee JH, Kim EH, Kim JT, Kim HS. Comparison of the TOFscan and the TOF-Watch SX during pediatric neuromuscular function recovery: a prospective observational study. Perioper Med (Lond). 2021;10(1):45. https://doi.org/10.1186/s13741-021-00215-2.CrossRef

40.

Blobner M, Hunter JM, Meistelman C, Hoeft A, Hollmann MW, Kirmeier E, et al. Use of a train-of-four ratio of 0.95 versus 0.9 for tracheal extubation: an exploratory analysis of POPULAR data. Br J Anaesth. 2020;124(1):63–72. https://doi.org/10.1016/j.bja.2019.08.023.CrossRef

41.

Driessen JJ, Robertson EN, Booij LH. Acceleromyography in neonates and small infants: baseline calibration and recovery of the responses after neuromuscular blockade with rocuronium. Eur J Anaesthesiol. 2005;22(1):11–5. https://doi.org/10.1017/s0265021505000037.CrossRef

42.

•• Unterbuchner C, Werkmann M, Ziegleder R, Kraus S, Seyfried T, Graf B, et al. Shortening of the twitch stabilization period by tetanic stimulation in acceleromyography in infants, children and young adults (STSTS-Study): a prospective randomised, controlled trial. J Clin Monit Comput. 2020;34(6):1343–9. https://doi.org/10.1007/s10877-019-00435-4A prospective randomized controlled trial highlighting the challenges of using acceleromyography in young patients.CrossRef

43.

Bowdle A, Bussey L, Michaelsen K, Jelacic S, Nair B, Togashi K, et al. A comparison of a prototype electromyograph vs. a mechanomyograph and an acceleromyograph for assessment of neuromuscular blockade. Anaesthesia. 2020;75(2):187–95. https://doi.org/10.1111/anae.14872.CrossRef

44.

Nemes R, Lengyel S, Nagy G, Hampton DR, Gray M, Renew JR, et al. Ipsilateral and simultaneous comparison of responses from acceleromyography- and electromyography-based neuromuscular monitors. Anesthesiology. 2021;135(4):597–611. https://doi.org/10.1097/ALN.0000000000003896.CrossRef

45.

Lee W. The latest trend in neuromuscular monitoring: return of the electromyography. Anesth Pain Med (Seoul). 2021;16(2):133–7. https://doi.org/10.17085/apm.21014.CrossRef

46.

Owusu-Bediako K KS, Rice-Weimer J, Tobias J. Quantitative train-of-four monitoring in pediatric patients using electromyography. ASA Annual Meeting Oct 09, 2021. 2021;ASA Abstract A4061(Virtual presentation). http://asaabstracts.com/strands/asaabstracts/abstract.htm?year=2021&index=8&absnum=5093.

47.

McCluskey A, Meakin G, Hopkinson JM, Baker RD. A comparison of acceleromyography and mechanomyography for determination of the dose-response curve of rocuronium in children. Anaesthesia. 1997;52(4):345–9. https://doi.org/10.1111/j.1365-2044.1997.104-az0101.x.CrossRef

48.

Jung W, Hwang M, Won YJ, Lim BG, Kong MH, Lee IO. Comparison of clinical validation of acceleromyography and electromyography in children who were administered rocuronium during general anesthesia: a prospective double-blinded randomized study. Korean J Anesthesiol. 2016;69(1):21–6. https://doi.org/10.4097/kjae.2016.69.1.21.CrossRef

49.

Sauer M, Stahn A, Soltesz S, Noeldge-Schomburg G, Mencke T. The influence of residual neuromuscular block on the incidence of critical respiratory events. A randomised, prospective, placebo-controlled trial. Eur J Anaesthesiol. 2011;28(12):842–8. https://doi.org/10.1097/EJA.0b013e328345cd11.CrossRef

50.

Eikermann M, Groeben H, Husing J, Peters J. Accelerometry of adductor pollicis muscle predicts recovery of respiratory function from neuromuscular blockade. Anesthesiology. 2003;98(6):1333–7. https://doi.org/10.1097/00000542-200306000-00006.CrossRef

51.

Kumar GV, Nair AP, Murthy HS, Jalaja KR, Ramachandra K, Parameshwara G. Residual neuromuscular blockade affects postoperative pulmonary function. Anesthesiology. 2012;117(6):1234–44. https://doi.org/10.1097/ALN.0b013e3182715b80.CrossRef

52.

Sundman E, Witt H, Olsson R, Ekberg O, Kuylenstierna R, Eriksson LI. The incidence and mechanisms of pharyngeal and upper esophageal dysfunction in partially paralyzed humans: pharyngeal videoradiography and simultaneous manometry after atracurium. Anesthesiology. 2000;92(4):977–84. https://doi.org/10.1097/00000542-200004000-00014.CrossRef

53.

Murphy GS, Szokol JW, Avram MJ, Greenberg SB, Shear T, Vender JS, et al. Postoperative residual neuromuscular blockade is associated with impaired clinical recovery. Anesth Analg. 2013;117(1):133–41. https://doi.org/10.1213/ANE.0b013e3182742e75.CrossRef

54.

Butterly A, Bittner EA, George E, Sandberg WS, Eikermann M, Schmidt U. Postoperative residual curarization from intermediate-acting neuromuscular blocking agents delays recovery room discharge. Br J Anaesth. 2010;105(3):304–9. https://doi.org/10.1093/bja/aeq157.CrossRef

55.

Grabitz SD, Rajaratnam N, Chhagani K, Thevathasan T, Teja BJ, Deng H, et al. The effects of postoperative residual neuromuscular blockade on hospital costs and intensive care unit admission: a population-based cohort study. Anesth Analg. 2019;128(6):1129–36. https://doi.org/10.1213/ANE.0000000000004028.CrossRef

56.

Kirmeier E, Eriksson LI, Lewald H, Jonsson Fagerlund M, Hoeft A, Hollmann M, et al. Post-anaesthesia pulmonary complications after use of muscle relaxants (POPULAR): a multicentre, prospective observational study. Lancet Respir Med. 2019;7(2):129–40. https://doi.org/10.1016/S2213-2600(18)30294-7.CrossRef

57.

Scheffenbichler FT, Rudolph MI, Friedrich S, Althoff FC, Xu X, Spicer AC, et al. Effects of high neuromuscular blocking agent dose on post-operative respiratory complications in infants and children. Acta Anaesthesiol Scand. 2020;64(2):156–67. https://doi.org/10.1111/aas.13478.CrossRef

58.

Ansermino JM, Sanderson PM, Bevan JC, Bevan DR. Acceleromyography improves detection of residual neuromuscular blockade in children. Can J Anaesth. 1996;43(6):589–94. https://doi.org/10.1007/bf03011772.CrossRef

59.

Martinez-Ubieto J, Ortega-Lucea S, Pascual-Bellosta A, Arazo-Iglesias I, Gil-Bona J, Jimenez-Bernardo T, et al. Prospective study of residual neuromuscular block and postoperative respiratory complications in patients reversed with neostigmine versus sugammadex. Minerva Anestesiol. 2016;82(7):735–42.

60.

•• Voss T, Wang A, DeAngelis M, Speek M, Saldien V, Hammer GB, et al. Sugammadex for reversal of neuromuscular blockade in pediatric patients: results from a phase IV randomized study. Paediatr Anaesth. 2022;32(3):436–45. https://doi.org/10.1111/pan.14370A randomized double-blind phase IV trial to determine dosing guidelines for sugammadex use in patients aged 2-17 years.CrossRef

61.

Gaver RS, Brenn BR, Gartley A, Donahue BS. Retrospective analysis of the safety and efficacy of sugammadex versus neostigmine for the reversal of neuromuscular blockade in children. Anesth Analg. 2019;129(4):1124–9. https://doi.org/10.1213/ANE.0000000000004207.CrossRef

62.

Alonso A, de Boer HD, Booij L. Reversal of rocuronium-induced neuromuscular block by sugammadex in neonates: 10AP1–3. Eur J Anaesthesiol. 2014;31:163.CrossRef

63.

Carlos RV, Torres ML, de Boer HD. Rocuronium and sugammadex in a 3 days old neonate for draining an ovarian cyst. Neuromuscular management and review of the literature. Braz J Anesthesiol. 2016;66(4):430–2. https://doi.org/10.1016/j.bjane.2015.01.004.CrossRef

64.

Matsui M, Konishi J, Suzuki T, Sekijima C, Miyazawa N, Yamamoto S. Reversibility of rocuronium-induced deep neuromuscular block with sugammadex in infants and children-a randomized study. Biol Pharm Bull. 2019;42(10):1637–40. https://doi.org/10.1248/bpb.b19-00044.CrossRef

65.

Lang B, Han L, Zeng L, Zhang Q, Chen S, Huang L, et al. Efficacy and safety of sugammadex for neuromuscular blockade reversal in pediatric patients: an updated meta-analysis of randomized controlled trials with trial sequential analysis. BMC Pediatr. 2022;22(1):295. https://doi.org/10.1186/s12887-022-03288-0.CrossRef

66.

Kheterpal S, Vaughn MT, Dubovoy TZ, Shah NJ, Bash LD, Colquhoun DA, et al. Sugammadex versus neostigmine for reversal of neuromuscular blockade and postoperative pulmonary complications (STRONGER): a multicenter matched cohort analysis. Anesthesiology. 2020;132(6):1371–81. https://doi.org/10.1097/ALN.0000000000003256.CrossRef

67.

Beltran RJ, Mpody C, Nafiu OO, Tobias JD. Association of sugammadex or neostigmine with major postoperative pulmonary complications in children. Anesth Analg. 2022. https://doi.org/10.1213/ane.0000000000005872.CrossRef

68.

• Carollo DS, White WM. Postoperative recurarization in a pediatric patient after sugammadex reversal of rocuronium-induced neuromuscular blockade: a case report. A A Pract. 2019;13(6):204–5. https://doi.org/10.1213/XAA.0000000000001023Case report documenting recurarization after sugammadex use in an infant.CrossRef

69.

• Lorinc AN, Lawson KC, Niconchuk JA, Modes KB, Moore JD, Brenn BR. Residual weakness and recurarization after sugammadex administration in pediatric patients: a case series. A A Pract. 2020;14(7): e01225. https://doi.org/10.1213/XAA.0000000000001225Case series documenting residual neuromuscular blockade after sugammadex use in infants.CrossRef

70.

Eleveld DJ, Kuizenga K, Proost JH, Wierda JM. A temporary decrease in twitch response during reversal of rocuronium-induced muscle relaxation with a small dose of sugammadex. Anesth Analg. 2007;104(3):582–4. https://doi.org/10.1213/01.ane.0000250617.79166.7f.CrossRef

71.

Woloszczuk-Gebicka B, Zawadzka-Glos L, Lenarczyk J, Sitkowska BD, Rzewnicka I. Two cases of the “cannot ventilate, cannot intubate” scenario in children in view of recent recommendations. Anaesthesiol Intensive Ther. 2014;46(2):88–91. https://doi.org/10.5603/AIT.2014.0017.CrossRef

72.

Wakimoto M, Burrier C, Tobias JD. Sugammadex for rapid intraoperative reversal of neuromuscular blockade in a neonate. J Med Cases. 2018;9(12):400–2. https://doi.org/10.14740/jmc3213.

73.

Efune PN, Alex G, Mehta SD. Emergency sugammadex reversal in an 850-G premature infant: a case report. J Pediatr Pharmacol Ther. 2021;26(1):107–10. https://doi.org/10.5863/1551-6776-26.1.107.CrossRef

74.

Apfelbaum JL, Hagberg CA, Connis RT, Abdelmalak BB, Agarkar M, Dutton RP, et al. 2022 American Society of Anesthesiologists practice guidelines for management of the difficult airway. Anesthesiology. 2022;136(1):31–81. https://doi.org/10.1097/aln.0000000000004002.CrossRef

Titel: Management of Neuromuscular Block in Pediatric Patients — Safety Implications
verfasst von: Young May Cha
Debra J. Faulk
Publikationsdatum: 13.09.2022
Verlag: Springer US
Erschienen in: Current Anesthesiology Reports / Ausgabe 4/2022
Elektronische ISSN: 2167-6275
DOI: https://doi.org/10.1007/s40140-022-00537-x

Neu im Fachgebiet AINS

Eingreifen von Umstehenden rettet vor Erstickungstod!

15.05.2024 Fremdkörperaspiration Nachrichten

Wer sich an einem Essensrest verschluckt und um Luft ringt, benötigt vor allem rasche Hilfe. Dass Umstehende nur in jedem zweiten Erstickungsnotfall bereit waren, diese zu leisten, ist das ernüchternde Ergebnis einer Beobachtungsstudie aus Japan. Doch es gibt auch eine gute Nachricht.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren

Springer Medizin

Management of Neuromuscular Block in Pediatric Patients — Safety Implications

Abstract

Purpose of Review

Recent Findings

Summary

Search Strategy

Neu im Fachgebiet AINS

Eingreifen von Umstehenden rettet vor Erstickungstod!

Darf man die Behandlung eines Neonazis ablehnen?

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

Häufigste Gründe für Brustschmerzen bei Kindern

Update AINS

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Search Strategy

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2022

Pediatric Neuroanesthesia — a Review of the Recent Literature

Impact of Closed-Loop Technology, Machine Learning, and Artificial Intelligence on Patient Safety and the Future of Anesthesia

Intraoperative Monitoring During Neurosurgical Procedures and Patient Outcomes

Patient Safety in Anesthesia: Hand Hygiene and Perioperative Infection Control

Hold the Phone! Perioperative Personal Electronic Devices

Correction to: Thrombin Generation in Trauma Patients: How Do We Navigate Through Scylla and Charybdis?

Neu im Fachgebiet AINS

Eingreifen von Umstehenden rettet vor Erstickungstod!

Darf man die Behandlung eines Neonazis ablehnen?

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

Häufigste Gründe für Brustschmerzen bei Kindern

Update AINS